Basics Arcus Biosciences, Inc. IPO Date: March 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $956.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 3.02% Avg Daily Range (30 D): $0.26 | 2.85% Avg Daily Range (90 D): $0.26 | 3.10% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 2,500 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $1.85M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.84M Avg Closing Trade (30 D): $1.68M Avg Closing Trade (90 D): $1.57M Avg Closing Volume: 134.19K     News Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.19 $-1.14 $-1.03 Diluted EPS $-4.19 $-1.14 $-1.03 Revenue $ 141M $ 28M $ 26M Gross Profit $ $ $ Net Income / Loss $ -391M $ -112M $ -94M Operating Income / Loss $ -436M $ -122M $ -103M Cost of Revenue $ $ $ Net Cash Flow $ 7M $ 42M $ -51M PE Ratio